Imperial College London

ProfessorMaudLemoine

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Professor and Honorary Consultant in Hepatology
 
 
 
//

Contact

 

+44 (0)20 3312 5212m.lemoine

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Summary

Dr Maud Lemoine is Professor and Honorary Consultant in Hepatology at St Mary’s hospital, Imperial College London, UK. She completed her medical degree and PhD in Paris, France. She also graduated in political sciences from the Institute of Political Studies in Paris. Her research activities are mainly focused on the prevention and management of viral hepatitis in resource-limited countries, mainly in Africa. Since 2011, she has been working with the Medical Research Council (MRC) The Gambia unit, as part of the hepatitisB PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa) programme in The Gambia and Senegal. She has been member of the WHO guideline development group for the management of chronic hepatitis B/C and is regularly commissioned by the WHO viral hepatitis unit for external reviews and consultancies

Funding: MRC UK, Wellcome Trust, ANRS, Gilead US and Viiv healthcare

Links: http://www.mrc.gm/screen-and-treat-scheme-for-hepatitis-b-may-prevent-deadly-complications-29-jul-2016/

Follow on twitter: @maud_lemoine

Publications

Journals

Im YR, Jagdish R, Leith D, et al., 2022, Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis, Lancet Gastroenterology & Hepatology, Vol:7, Pages:932-942

Ndow G, Cessay A, Cohen D, et al., 2022, Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West Africa., Journal of Infectious Diseases, Vol:226, ISSN:0022-1899, Pages:862-870

Lemoine M, Assoumou L, Girard P-M, et al., 2022, Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study., Clin Gastroenterol Hepatol

Boyer S, Baudoin M, Nishimwe ML, et al., 2022, Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa, Bmc Health Services Research, Vol:22, ISSN:1472-6963, Pages:1-15

Gill US, Lemoine M, 2022, Making safe sense of an anti-sense!, Cell Reports Medicine, Vol:3, ISSN:2666-3791, Pages:1-2

More Publications